SDG

sdg develops cell targeting and oral formulation nanotechnology systems for use in drug delivery systems and in consumer product applications. sdg's patented systems are used in the creation and development of novel oral delivery systems for insulin, interferon, and other protein-based therapies, cell-receptor targeting of a wide variety oflarge and small molecule drugs and diagnostics, and consumer products ranging from hair conditioners and styling agents to skin-adhering insect repellents and sunscreens.these systems are suited for use as cell receptor-targeted vehicles in personalized medicine strategies for cancer. sdg's technologies have shown to be safe and efficacious in various disease categories, including diabetes and hepatitis.